Skip to main content
Portrait of Anil Bhansali

MDRPEDIA RECORDELITE · TIER IILIVING

Anil Bhansali

Endocrinology (Diabetes Complications) · PGIMER Chandigarh · India

Suggest a correction
ELITE · TIER II · MDRPEDIA · LISTED 2026 ·MTIER II
h-index (OpenAlex)
110
Papers on record
48
Stature
Tier II
Years in practice
35
Last updated
18 Feb 26
EVIDENCE RECORD

What this record is built on

Compared with the register: Internal Medicine · India · 35 years in practice · How it works

I · SCHOLARSHIP

h-index
110 · 72nd pct
OpenAlex◐ Public record
Papers on record
48
Crossref / DOI◐ Public record
Citations received
—
OpenAlex○ Not reported

II · PRACTICE

Licence
Not yet checked
Medical council○ Not reported
Board certification
—
Specialty boards○ Not reported
Registration ID
—
National registry○ Not reported
Institutions
2
Institution records◐ Public record

III · LEARNING & TEACHING

Trainees traced
Not yet traced
Lineage○ Not reported
Mentors traced
Not yet traced
Lineage○ Not reported
Invited talks
—
Congress programmes○ Not reported

IV · PEER STANDING

Honours
—
Awarding bodies○ Not reported
Techniques pioneered
—
Published literature○ Not reported
Ethics mark
Not yet audited
MDRPedia audit○ Not reported

Not on this record by design:Star ratingsAnonymous reviewsPaid placement

Record

Dr. Anil Bhansali is a distinguished endocrinologist and former Head of the Department of Endocrinology at PGIMER, Chandigarh. With over 30 years of teaching and research experience, he is a leading authority on diabetes and metabolic disorders in India. He has authored several foundational textbooks, including 'Clinical Rounds in Endocrinology', and has over 500 scientific publications. He is a recipient of the prestigious Dr. B. C. Roy Award in the Eminent Medical Teacher category.
IN PLAIN WORDS
  • Practicing diabetes complications specialist with 35+ years of experience
  • Currently at PGIMER Chandigarh in India

Institutions

QUESTIONS YOU MIGHT ASK AT A FIRST VISIT
  • Is a procedure needed now, or can medicines and lifestyle changes help first?
  • What are the risks and benefits of each option for someone like me?
  • How many similar cases does your team see, and who will be involved in my care?
  • Who do I contact if symptoms come back after treatment?

Landmark papers

Papers on record
48
Papers on record by year, 1999–2022

PUBLISHED IN Kidney International · The Lancet · The Lancet Planetary Health · The Lancet Diabetes & Endocrinology · The Lancet Global Health

  1. 2022Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)The Lancet Diabetes & Endocrinologydoi 10.1016/s2213-8587(23)00119-5
  2. 2022Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17).The lancet. Diabetes & endocrinologydoi 10.1016/S2213-8587(23)00119-5
  3. 2022Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline UpdateAnnals of Internal Medicinedoi 10.7326/m22-2904
  4. 2022Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes CompactThe Lancetdoi 10.1016/s0140-6736(23)00001-6
  5. 2022The burgeoning cardiovascular disease epidemic in Indians – perspectives on contextual factors and potential solutionsThe Lancet Regional Health - Southeast Asiadoi 10.1016/j.lansea.2023.100156
Show all 48 papersShow fewer papers
  1. 2021KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney DiseaseKidney Internationaldoi 10.1016/j.kint.2022.06.008
  2. 2021Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidenceKidney Internationaldoi 10.1016/j.kint.2022.06.013
  3. 2021Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).Postgraduate medical journaldoi 10.1136/postgradmedj-2020-139065
  4. 2021The impact of the COVID-19 pandemic on diabetes services: planning for a global recoveryThe Lancet Diabetes & Endocrinologydoi 10.1016/s2213-8587(22)00278-9
  5. 2020The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990–2019The Lancet Global Healthdoi 10.1016/s2214-109x(21)00164-9
  6. 2020Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods studyBMC Public Healthdoi 10.1186/s12889-021-10708-w
  7. 2019Health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019The Lancet Planetary Healthdoi 10.1016/s2542-5196(20)30298-9
  8. 2019Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatmentKidney Internationaldoi 10.1016/j.kint.2020.06.024
  9. 2019Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice GuidelineAnnals of Internal Medicinedoi 10.7326/m20-5938
  10. 2019Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in IndiaJAMAdoi 10.1001/jama.2020.11747
  11. 2018Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary CareCirculationdoi 10.1161/circulationaha.118.038192
  12. 2017The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017The Lancet Planetary Healthdoi 10.1016/s2542-5196(18)30261-4
  13. 2017The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016The Lancet Global Healthdoi 10.1016/s2214-109x(18)30387-5
  14. 2017The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016The Lancet Global Healthdoi 10.1016/s2214-109x(18)30407-8
  15. 2017ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youthPediatric Diabetesdoi 10.1111/pedi.12719
  16. 2017Multimorbidity in South Asian adults: prevalence, risk factors and mortalityJournal of Public Healthdoi 10.1093/pubmed/fdy017
  17. 2016Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease StudyThe Lancetdoi 10.1016/s0140-6736(17)32804-0
  18. 2016Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd editionThe Lancetdoi 10.1016/s0140-6736(17)32471-6
  19. 2016Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directionsBMJdoi 10.1136/bmj.j1420
  20. 2015Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care GoalsAnnals of Internal Medicinedoi 10.7326/m15-2807
  21. 2014Association between maternal age at childbirth and child and adult outcomes in the offspring: a prospective study in five low-income and middle-income countries (COHORTS collaboration)The Lancet Global Healthdoi 10.1016/s2214-109x(15)00038-8
  22. 2014A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, IndiaCirculationdoi 10.1161/circulationaha.115.015373
  23. 2014High burden of prediabetes and diabetes in three large cities in South Asia: The Center for cArdio-metabolic Risk Reduction in South Asia (CARRS) StudyDiabetes Research and Clinical Practicedoi 10.1016/j.diabres.2015.09.005
  24. 2014Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statementIndian Journal of Endocrinology and Metabolismdoi 10.4103/2230-8210.163171
  25. 2013Type 2 diabetes in the child and adolescentPediatric Diabetesdoi 10.1111/pedi.12179
  26. 2013Management of NCD in Low- and Middle-Income CountriesGlobal Heartdoi 10.1016/j.gheart.2014.11.003
  27. 2012A Study of Insulin Resistance by HOMA-IR and its Cut-off Value to Identify Metabolic Syndrome in Urban Indian AdolescentsJournal of Clinical Research in Pediatric Endocrinologydoi 10.4274/jcrpe.1127
  28. 2011Genome-Wide Association Study for Type 2 Diabetes in Indians Identifies a New Susceptibility Locus at 2q21Diabetesdoi 10.2337/db12-0406
  29. 2011CARRS Surveillance study: design and methods to assess burdens from multiple perspectivesBMC Public Healthdoi 10.1186/1471-2458-12-701
  30. 2010Overt and Subclinical HypothyroidismDrugsdoi 10.2165/11598070-000000000-00000
  31. 2010Size at Birth, Weight Gain in Infancy and Childhood, and Adult Diabetes Risk in Five Low- or Middle-Income Country Birth CohortsDiabetes Caredoi 10.2337/dc11-0456
  32. 2010Vitamin D status in pregnant Indian women across trimesters and different seasons and its correlation with neonatal serum 25-hydroxyvitamin D levelsBritish Journal Of Nutritiondoi 10.1017/s000711451100170x
  33. 2010Bone health in healthy Indian population aged 50 years and aboveOsteoporosis Internationaldoi 10.1007/s00198-010-1507-8
  34. 2009Impact of Common Variants of <i>PPARG</i>, <i>KCNJ11</i>, <i>TCF7L2</i>, <i>SLC30A8</i>, <i>HHEX</i>, <i>CDKN2A</i>, <i>IGF2BP2</i>, and <i>CDKAL1</i> on the Risk of Type 2 Diabetes in 5,164 IndiansDiabetesdoi 10.2337/db09-1386
  35. 2008Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based surveyBritish Journal Of Nutritiondoi 10.1017/s0007114509220824
  36. 2007Adult Metabolic Syndrome and Impaired Glucose Tolerance Are Associated With Different Patterns of BMI Gain During InfancyDiabetes Caredoi 10.2337/dc08-0911
  37. 2006Vitamin D status of apparently healthy schoolgirls from two different socioeconomic strata in Delhi: relation to nutrition and lifestyleBritish Journal Of Nutritiondoi 10.1017/s0007114507831758
  38. 2005Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian IndiansAmerican Journal of Clinical Nutritiondoi 10.1093/ajcn/83.6.1411
  39. 2004Vitamin D and bone mineral density status of healthy schoolchildren in northern IndiaAmerican Journal of Clinical Nutritiondoi 10.1093/ajcn.82.2.477
  40. 2004Vitamin D and bone mineral density status of healthy schoolchildren in northern IndiaAmerican Journal of Clinical Nutritiondoi 10.1093/ajcn/82.2.477
  41. 2002Residual goitre in the postiodization phase: iodine status, thiocyanate exposure and autoimmunityClinical Endocrinologydoi 10.1046/j.1365-2265.2003.01895.x
  42. 2000Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed ratsJournal of Ethnopharmacologydoi 10.1016/s0378-8741(01)00218-5
  43. 1999Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in DelhiAmerican Journal of Clinical Nutritiondoi 10.1093/ajcn/72.2.472

Lineage

We haven't traced this physician's mentors and trainees yet. If you trained with them, you can add to the record.Contribute lineage
FOR THE DOCTOR

Are you Anil Bhansali?

Claim this record to correct details, add your lineage and teaching, and embed your seal. Claims are checked against your registration before anything changes.

Share this record

Share card for Anil Bhansali